Literature DB >> 30701230

Draft Genome Sequences for Dual-Toxin-Producing Clostridium botulinum Strains.

Jessica L Halpin1, Janet K Dykes1, Carolina Lúquez1.   

Abstract

Here, we present draft genome sequences for three Clostridium botulinum strains that produce multiple botulinum toxin serotypes. Strains that produce two toxins are rare; however, one of these strains produces subtype B5 and F2 toxins, and two of the strains produce subtype A4 and B5 toxins.

Entities:  

Year:  2019        PMID: 30701230      PMCID: PMC6346179          DOI: 10.1128/MRA.01152-18

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Botulism is a rare but serious neuroparalytic disease that is caused by botulinum neurotoxins (1). These toxins are produced by Clostridium botulinum and, rarely, other Clostridia species and cause four different types of disease (2), foodborne botulism, infant botulism, wound botulism, and adult intestinal colonization. Rarely, strains may produce more than one toxin type (3–8), and they are denoted as bivalent toxin producers, with the major toxin written as an uppercase letter and the minor toxin as a lowercase letter. Only three combinations of bivalent toxin producers have been identified, as follows: B and F, A and F, and A and B (e.g., Ab, Ba, Bf, and Af). C. botulinum strain CDC69057 was isolated (9) from a case of infant botulism during routine investigation and determined to be serotype Bf, subtypes B5 and F2. Previous bivalent Bf strains have shared these subtypes (10). C. botulinum CDC60006 was isolated (9) from a case of infant botulism and determined to be serotype AB, subtypes A4 and B5. C. botulinum CDC69043 was isolated from a baked potato during a foodborne botulism investigation and determined to be serotype Ba, subtypes A4 and B5. These two isolates were divided by time and geography and are not believed to be related. The isolates were retrieved from long-term storage, inoculated into chopped meat glucose starch (CMGS) broth, and grown at 33 to 37°C anaerobically for 24 h. The culture was streaked onto egg yolk agar for isolation. A single colony was inoculated into Trypticase soy glucose yeast (TPGY) broth and grown anaerobically for 16 to 18 h prior to genomic DNA extraction. DNA extraction was performed using a modified MasterPure complete DNA and RNA purification kit (Lucigen, Middleton, WI). Sequencing was performed on the Ion Torrent Personal Genome Machine (11), with 200-bp libraries created with the Kapa Biosciences kit (12). Raw reads were assessed with FastQC (13) and assembled using SPAdes version 3.1.0 (14), with the following settings enabled: k = 21,33,55,77,99,127; -s; –careful; –iontorrent. Assemblies were assessed using Quast version 4.0 (15). Plasmid SPAdes was run using the same settings plus the –plasmid flag. The traditional 7-gene multilocus sequence type (MLST) (16) was determined by querying assemblies against the Center for Genomic Epidemiology MLST 2.0 site (17). Unicycler version 0.4.4 was run with default settings and the single end flag enabled. The Map Reads to Reference tool was utilized within CLC Genomics Workbench, with default settings, to map the reads to plasmid references. CDC69057 sequencing resulted in 521,912 reads, with an average size of 170 bp, 23× average coverage, 220 contigs, and an N50 value of 34,270 bp. The sequence has a GC content of 27.96% and belongs to the 7-gene multilocus sequence type 14 (ST14) (16, 18), which is a very small group. In addition to CDC69057, the PubMLST database contains only 5 isolates with ST14. Four of these isolates are serotype Bf (subtypes B2 and F2) and were isolated during several events in France. One isolate is listed as having an unknown source location and is serotype A(B). Sequencing coverage was not sufficient to confirm the presence of a plasmid, but the reads map with 6.56× average coverage across about 50% of the pCLJ reference from strain CDC657, a dual-toxin-producing strain. CDC60006 sequencing resulted in 508,444 reads, with an average size of 190 bp, 25× average coverage, 135 contigs, and an N50 value of 68,652 bp. CDC69043 sequencing resulted in 794,471 reads, with an average size of 222 bp, 46× average coverage, 93 contigs, and an N50 value of 161,283 bp. Both sequences have a GC content of 27.9% and belong to the 7-gene MLST ST7, which is only one allele different from the previously mentioned ST14. ST7 has 23 members on PubMLST from Argentina, France, and the United States and is composed of serotype A in the form of A(B), as well as subtypes A4 and A2. CDC60006 sequencing did not yield conclusive results regarding plasmid presence, possibly due to low coverage. The reads mapped to pCLJ with 10.92× average coverage across about 64% of the reference plasmid from strain CDC657, and these did include toxin genes. Plasmid SPAdes was able to assemble pCLJ2 out of the CDC69043 reads, and Unicycler (19) was able to construct pCLJ, which also included both toxin genes. Plasmids very similar to pCLJ and pCLJ2 reside within CDC69043, and the toxin genes are found within pCLJ.

Data availability.

These sequences have been deposited under SRA accession numbers SRS4007694 (CDC60006), SRS4007621 (CDC69057), and SRS4007620 (CDC69043) and GenBank accession numbers QVAF00000000 (CDC60006), QVAG00000000 (CDC69043), and QVAH00000000 (CDC69057).
  15 in total

1.  Multilocus sequence typing of total-genome-sequenced bacteria.

Authors:  Mette V Larsen; Salvatore Cosentino; Simon Rasmussen; Carsten Friis; Henrik Hasman; Rasmus Lykke Marvig; Lars Jelsbak; Thomas Sicheritz-Pontén; David W Ussery; Frank M Aarestrup; Ole Lund
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Assembling single-cell genomes and mini-metagenomes from chimeric MDA products.

Authors:  Sergey Nurk; Anton Bankevich; Dmitry Antipov; Alexey A Gurevich; Anton Korobeynikov; Alla Lapidus; Andrey D Prjibelski; Alexey Pyshkin; Alexander Sirotkin; Yakov Sirotkin; Ramunas Stepanauskas; Scott R Clingenpeel; Tanja Woyke; Jeffrey S McLean; Roger Lasken; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2013-10       Impact factor: 1.479

Review 3.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  QUAST: quality assessment tool for genome assemblies.

Authors:  Alexey Gurevich; Vladislav Saveliev; Nikolay Vyahhi; Glenn Tesler
Journal:  Bioinformatics       Date:  2013-02-19       Impact factor: 6.937

5.  First report of an infant botulism case due to Clostridium botulinum type Af.

Authors:  Laura I T de Jong; Rafael A Fernández; Virtudes Pareja; Gabriel Giaroli; Sergio R Guidarelli; Janet K Dykes; Carolina Lúquez
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

6.  Sequence diversity of genes encoding botulinum neurotoxin type F.

Authors:  Brian H Raphael; Mallory J Choudoir; Carolina Lúquez; Rafael Fernández; Susan E Maslanka
Journal:  Appl Environ Microbiol       Date:  2010-05-28       Impact factor: 4.792

7.  Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing.

Authors:  Mark J Jacobson; Guangyun Lin; Thomas S Whittam; Eric A Johnson
Journal:  Microbiology       Date:  2008-08       Impact factor: 2.777

8.  Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism.

Authors:  Jason R Barash; Stephen S Arnon
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Authors:  Keith A Jolley; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2010-12-10       Impact factor: 3.169

10.  Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.

Authors:  Theresa J Smith; Karen K Hill; Brian T Foley; John C Detter; A Christine Munk; David C Bruce; Norman A Doggett; Leonard A Smith; James D Marks; Gary Xie; Thomas S Brettin
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.